Osimertinib Drug Interactions
- Tagrisso
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
About Osimertinib
Osimertinib is a kinase inhibitor used to treat certain types of non-small-cell lung cancer that has spread or to prevent it from returning after surgery.
Read the full Osimertinib drug information pageQuick links
The Bottom Line on Osimertinib
Ondansetron is the pairing to know about first: taken alongside osimertinib, it can raise the risk of a heart rhythm change called QT prolongation. Hydroxyzine, another medicine many people take, is rated major for the same reason.
Osimertinib is a daily tablet that treats certain lung cancers that have spread, and helps keep them from coming back after surgery. It has more documented interactions than most medicines, and most of them are rated major or contraindicated. Heart effects are the problem that turns up most often, followed by changes in how much medicine is in the blood and medicines that work less well.
Because the list is long, tell every prescriber, a dentist or an urgent care clinic included, that you take osimertinib before anything new is started.
From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy
Check Osimertinib Against Another Drug or Supplement
Type a drug, a brand name or a supplement. We check it against every documented osimertinib interaction, supplements and herbs included.
What Could Happen When Osimertinib Interacts
What the 348 documented osimertinib interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.
This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site. One interaction can name more than one problem, so the numbers add up to more than 348.
Osimertinib Interactions by Severity
Contraindicated
- Osimertinib and Colchicine Explained Brand names: Colcrys, Gloperba, Mitigare Increased colchicine exposure and an increased risk of colchicine toxicity Details
- Osimertinib and Dronedarone Explained Brand name: Multaq Increased risk of QT interval prolongation Details
- Osimertinib and Levoketoconazole Explained Brand name: Recorlev An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details
- Osimertinib and Bacillus of Calmette and Guerin Vaccine, Live Explained An increased risk of infection by the live vaccine Details
- Osimertinib and Bepridil Explained An increased risk of QT interval prolongation Details
- Osimertinib and Cisapride Explained Brand name: Propulsid Increased risk of QT interval prolongation Details
- Osimertinib and Dengue Tetravalent Vaccine, Live Explained An increased risk of infection by the live vaccine Details
- Osimertinib and Measles Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details
- Osimertinib and Mesoridazine Explained Brand name: Serentil An increased risk of QT interval prolongation Details
- Osimertinib and Mumps Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details
- Osimertinib and Pimozide Explained Brand name: Orap An increased risk of QT interval prolongation Details
- Osimertinib and Piperaquine Explained An increased risk of QT interval prolongation Details
- Osimertinib and Rubella Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details
- Osimertinib and Saquinavir Explained Brand name: Invirase An increased risk of QT interval prolongation Details
- Osimertinib and Smallpox Monkeypox Vaccine Explained An increased risk of infection by the live vaccine Details
- Osimertinib and Sparfloxacin Explained An increased risk of QT interval prolongation Details
- Osimertinib and Terfenadine Explained An increased risk of QT interval prolongation Details
- Osimertinib and Thioridazine Explained Brand name: Mellaril An increased risk of QT interval prolongation Details
- Osimertinib and Typhoid Vaccine Explained Brand names: Typhim VI, Vivotif An increased risk of infection by the live vaccine Details
- Osimertinib and Varicella Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details
Look Up Another Drug
Still Have Questions About Osimertinib?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
The References Behind Osimertinib’s Interactions
The 181 sources our osimertinib interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →
- Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2024. DailyMed
- Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2024. DailyMed
- Planchard D, Janne PA, Cheng Y, et al: Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med 2023; 389(21):1935-1948.
- Product Information: TAGRISSO® oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP, Wilmington, DE, 2026. DailyMed
- Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2024. DailyMed
- Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2020. DailyMed
- Wu Y-L, Tsuboi M, He J, et al: Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med 2020; 383(18):1711-1723.
- Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per manufacturer), Wilmington, DE, 2018. DailyMed
- Soria JC, Ohe Y, Vansteenkiste J, et al: Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 2018; 378(2):113-125.
- Ramalingam SS, Vansteenkiste J, Planchard D, et al: Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med 2020; 382(1):41-50.